跳到正文
原文
Nature 健康护理主题·· 2026-10-18AI 评分33

一项关于褪黑素补充剂对超重/肥胖女性血浆2-花生二酸甘油酯、饥饿素和快感食欲强度影响的随机对照试验

A pilot randomized controlled trial of melatonin supplementation on plasma 2-arachidonoylglycerol, ghrelin, and hedonic appetite intensity in females with overweight/obesity

AI 导读

一项随机对照试验表明,在超重或肥胖且快感食欲高的女性中,补充褪黑素 8 周后血浆饥饿素显著降低(4.35±0.90 vs. 4.78±0.75 pg/mL; p=0.013)。试验未发现褪黑素对血浆 2-花生二酸甘油酯、快感食欲强度、饮食摄入或体重产生显著的组间差异。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Hedonic appetite, the motivation to consume palatable foods for pleasure rather than physiological need, may contribute to overweight and obesity, yet few interventions have targeted it. This pilot randomized, placebo-controlled trial examined the effects of melatonin supplementation on plasma 2-arachidonoylglycerol (2-AG), ghrelin, hedonic appetite intensity, dietary intake, and body weight in women with overweight or obesity. Forty-one participants with high hedonic appetite (Power of Food Scale score > 2.5) completed the trial. Participants received either 5 mg/day melatonin (n = 21) or placebo (n = 20) for 8 weeks. 2-AG, ghrelin, and hedonic appetite were assessed at baseline and week 8, whereas dietary intake and body weight were assessed at baseline, week 4, and week 8. ANCOVA or Quade’s ANCOVA was used to compare outcomes between groups. Mean age and BMI were 35.68 ± 7.51 years and 30.36 ± 2.40 kg/m2, respectively. At the end of the intervention, plasma ghrelin was significantly lower in the melatonin group than in the placebo group (4.35 ± 0.90 pg/mL vs. 4.78 ± 0.75 pg/mL; p = 0.013). No significant between-group differences were observed for the other outcomes. Melatonin’s effect on lowering ghrelin, without significant effects on 2-AG or hedonic appetite, means that any impact on hedonic appetite remains uncertain.

Trial registration: The trial was prospectively registered with the Iranian Registry of Clinical Trials (https://irct.behdasht.gov.ir/trial/70034) in 21/06/2023 under the ID number IRCT20080904001197N22.

Acknowledgements

This manuscript is based on data generated from the second phase of a Ph.D. dissertation conducted at Tabriz University of Medical Sciences, Tabriz, Iran (registration number IR.TBZMED.REC.1402.075). The authors gratefully acknowledge Tehran Darou Company (Tehran, Iran) for supplying the melatonin supplements and placebos, and they extend their sincere appreciation to all participants for their time and cooperation.

Funding

This project was financially supported by Tabriz University of Medical Sciences (Grant No. 71422). The funding body had no involvement in the study’s conceptualization, design, data acquisition, analysis, interpretation, decision to publish, or manuscript preparation.

Author information

Authors and Affiliations

  1. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

    Malihe Karamizadeh & Maryam Parimi

  2. Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

    Malihe Karamizadeh & Maryam Parimi

  3. Nutrition Research Laboratory, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

    Leila Sadeghi

  4. Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

    Marzieh Akbarzadeh

  5. Nutrition Research Center, Department of Biochemistry and Diet Therapy, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

    Reza Mahdavi & Bahram Pourghassem Gargari

Authors

  1. Malihe Karamizadeh
  2. Maryam Parimi
  3. Leila Sadeghi
  4. Marzieh Akbarzadeh
  5. Reza Mahdavi
  6. Bahram Pourghassem Gargari

Corresponding authors

Correspondence to Reza Mahdavi or Bahram Pourghassem Gargari.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karamizadeh, M., Parimi, M., Sadeghi, L. et al. A pilot randomized controlled trial of melatonin supplementation on plasma 2-arachidonoylglycerol, ghrelin, and hedonic appetite intensity in females with overweight/obesity. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76450-8

Download citation

  • Received: 26 June 2026

  • Accepted: 13 October 2026

  • Published: 18 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-76450-8

Keywords

来源:Nature 健康护理主题 · nature.com